+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Cystic Fibrosis Market by Product Type (Anti Inflammatories, Antibiotics, CFTR Modulator Therapy), Route Of Administration (Inhalation, Intravenous, Oral), End User, Distribution Channel - Global Forecast 2025-2030- Product Image
Cystic Fibrosis Market by Product Type (Anti Inflammatories, Antibiotics, CFTR Modulator Therapy), Route Of Administration (Inhalation, Intravenous, Oral), End User, Distribution Channel - Global Forecast 2025-2030- Product Image
Sale

Cystic Fibrosis Market by Product Type (Anti Inflammatories, Antibiotics, CFTR Modulator Therapy), Route Of Administration (Inhalation, Intravenous, Oral), End User, Distribution Channel - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 187 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6084162
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The global cystic fibrosis market is evolving rapidly, shaped by scientific advancements, changing regulatory frameworks, and a focus on precision-based therapies. Senior decision-makers face an environment where innovation, supply chain resilience, and strategic alliances are central to success within this competitive landscape.

Market Snapshot: Cystic Fibrosis Therapeutics Market

The cystic fibrosis market grew from USD 6.44 billion in 2024 to USD 7.07 billion in 2025. It is forecast to expand at a CAGR of 9.56%, reaching USD 11.14 billion by 2030. This expansion reflects ongoing transformation driven by targeted therapies, precision diagnostics, and strategic investment by leading biopharmaceuticals. The market’s dynamic growth trajectory underscores a pivotal opportunity for innovative approaches across the therapeutic value chain.

Scope & Segmentation

This research delivers comprehensive analysis and segmentation to facilitate actionable decision-making. The study covers the full landscape of cystic fibrosis management, enabling leaders to align strategies with evolving needs:

  • Product Type: Anti-inflammatories, antibiotics, CFTR modulator therapy (including elexacaftor-tezacaftor-ivacaftor, ivacaftor, lumacaftor-ivacaftor, tezacaftor-ivacaftor), mucolytics, pancreatic enzymes.
  • Route of Administration: Inhalation, intravenous, oral.
  • End User: Home healthcare, hospitals, specialty clinics.
  • Distribution Channel: Offline pharmacy (hospital and retail pharmacy), online pharmacy.
  • Regional Coverage: Americas (United States including California, Texas, New York, Florida, Illinois, Pennsylvania, and Ohio; Canada; Mexico; Brazil; Argentina), Europe, Middle East & Africa (United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan).
  • Technologies: CFTR modulators, gene therapies, advanced small molecules, digital health integration, and real-world evidence generation.
  • Leading Companies: Vertex Pharmaceuticals Incorporated, F. Hoffmann-La Roche Ltd, Novartis AG, Gilead Sciences Inc., Teva Pharmaceutical Industries Ltd, Viatris Inc., Sun Pharmaceutical Industries Ltd, Cipla Limited, Lupin Limited, AbbVie.

Key Takeaways

  • Precision-based treatment approaches and next-generation modalities are redefining standards of care by targeting cystic fibrosis at the molecular level.
  • Collaboration among biopharma innovators, academic centers, and advocacy groups is accelerating therapeutic development and regulatory approvals.
  • Digital health adoption, including telehealth and remote monitoring, is improving adherence and enabling more flexible clinical trial models.
  • Increasing investment in patient registries and real-world data supports deeper understanding of treatment effectiveness and safety profiles across diverse populations.
  • Regional infrastructure and policy differences continue to shape access, reimbursement, and adoption rates for novel treatments, driving the need for tailored market entry strategies.
  • Robust supply chains, fostered by diversified sourcing and domestic manufacturing, are critical to addressing potential disruptions and meeting rising demand.

Impact of United States Tariff Measures

Recent adjustments to United States tariff regulations have resulted in higher costs for certain pharmaceutical components, prompting manufacturers to reconsider sourcing strategies. Companies are responding through diversification of supplier networks and expansion of domestic manufacturing, limiting exposure to cross-border price volatility. These measures are influencing payer negotiations, driving the exploration of risk-sharing agreements, and requiring regulatory flexibility to ensure uninterrupted patient access.

Methodology & Data Sources

This analysis integrates a rigorous blend of secondary data review and primary research. Peer-reviewed literature, regulatory documents, proprietary company disclosures, and clinical trial databases form the knowledge base. Primary insights come from structured interviews with leading clinicians, payers, and advocacy groups, validated through historical trends and real-world evidence.

Why This Report Matters

  • Enables senior executives to make strategic investment decisions grounded in detailed segmentation by product type, region, and technology adoption.
  • Identifies emerging risks and opportunities tied to regulatory, supply chain, and reimbursement trends, supporting long-term resilience planning.
  • Delivers uniquely actionable insights through integrated primary and secondary research, empowering confident navigation of a complex therapeutic ecosystem.

Conclusion

The global cystic fibrosis market presents a landscape shaped by scientific progress, regulatory adaptation, and evolving patient needs. Organizations equipped with a deep understanding of these dynamics will be best positioned to advance standards of care and capture sustainable growth opportunities.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rapid adoption of triple combination CFTR modulator therapies in broad patient populations, improving clinical outcomes
5.2. Emergence of CRISPR and gene editing approaches targeting underlying CF mutations in clinical trial pipelines
5.3. Integration of telehealth platforms and remote monitoring devices for continuous cystic fibrosis patient management
5.4. Expansion of specialty care center networks to support multidisciplinary cystic fibrosis treatment and patient education
5.5. Rising emphasis on real-world evidence collection through patient registries to inform CF therapy effectiveness and safety
5.6. Payer-driven cost-effectiveness evaluations influencing access to cystic fibrosis orphan drugs and reimbursement decisions
5.7. Growth of personalized medicine initiatives leveraging CFTR genotyping for mutation-specific treatment selection and outcomes
5.8. Development of next-generation inhaled formulations to enhance drug delivery and adherence in cystic fibrosis therapy
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Cystic Fibrosis Market, by Product Type
8.1. Introduction
8.2. Anti Inflammatories
8.3. Antibiotics
8.4. CFTR Modulator Therapy
8.4.1. Elexacaftor Tezacaftor Ivacaftor
8.4.2. Ivacaftor
8.4.3. Lumacaftor Ivacaftor
8.4.4. Tezacaftor Ivacaftor
8.5. Mucolytics
8.6. Pancreatic Enzymes
9. Cystic Fibrosis Market, by Route Of Administration
9.1. Introduction
9.2. Inhalation
9.3. Intravenous
9.4. Oral
10. Cystic Fibrosis Market, by End User
10.1. Introduction
10.2. Home Healthcare
10.3. Hospitals
10.4. Specialty Clinics
11. Cystic Fibrosis Market, by Distribution Channel
11.1. Introduction
11.2. Offline Pharmacy
11.2.1. Hospital Pharmacy
11.2.2. Retail Pharmacy
11.3. Online Pharmacy
12. Americas Cystic Fibrosis Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Cystic Fibrosis Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Cystic Fibrosis Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Vertex Pharmaceuticals Incorporated
15.3.2. F. Hoffmann-La Roche Ltd
15.3.3. Novartis AG
15.3.4. Gilead Sciences, Inc.
15.3.5. Teva Pharmaceutical Industries Ltd
15.3.6. Viatris Inc.
15.3.7. Sun Pharmaceutical Industries Ltd
15.3.8. Cipla Limited
15.3.9. Lupin Limited
15.3.10. AbbVie
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. CYSTIC FIBROSIS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL CYSTIC FIBROSIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS CYSTIC FIBROSIS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS CYSTIC FIBROSIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES CYSTIC FIBROSIS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES CYSTIC FIBROSIS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC CYSTIC FIBROSIS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC CYSTIC FIBROSIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. CYSTIC FIBROSIS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. CYSTIC FIBROSIS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. CYSTIC FIBROSIS MARKET: RESEARCHAI
FIGURE 24. CYSTIC FIBROSIS MARKET: RESEARCHSTATISTICS
FIGURE 25. CYSTIC FIBROSIS MARKET: RESEARCHCONTACTS
FIGURE 26. CYSTIC FIBROSIS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. CYSTIC FIBROSIS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CYSTIC FIBROSIS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL CYSTIC FIBROSIS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY ANTI INFLAMMATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY ANTI INFLAMMATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY CFTR MODULATOR THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY CFTR MODULATOR THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY ELEXACAFTOR TEZACAFTOR IVACAFTOR, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY ELEXACAFTOR TEZACAFTOR IVACAFTOR, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY IVACAFTOR, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY IVACAFTOR, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY LUMACAFTOR IVACAFTOR, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY LUMACAFTOR IVACAFTOR, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY TEZACAFTOR IVACAFTOR, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY TEZACAFTOR IVACAFTOR, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY CFTR MODULATOR THERAPY, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY CFTR MODULATOR THERAPY, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY MUCOLYTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY MUCOLYTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY PANCREATIC ENZYMES, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY PANCREATIC ENZYMES, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY INHALATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY INHALATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY OFFLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY OFFLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY OFFLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY OFFLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. AMERICAS CYSTIC FIBROSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 60. AMERICAS CYSTIC FIBROSIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 61. AMERICAS CYSTIC FIBROSIS MARKET SIZE, BY CFTR MODULATOR THERAPY, 2018-2024 (USD MILLION)
TABLE 62. AMERICAS CYSTIC FIBROSIS MARKET SIZE, BY CFTR MODULATOR THERAPY, 2025-2030 (USD MILLION)
TABLE 63. AMERICAS CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 64. AMERICAS CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS CYSTIC FIBROSIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS CYSTIC FIBROSIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS CYSTIC FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS CYSTIC FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS CYSTIC FIBROSIS MARKET SIZE, BY OFFLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS CYSTIC FIBROSIS MARKET SIZE, BY OFFLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS CYSTIC FIBROSIS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS CYSTIC FIBROSIS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 73. UNITED STATES CYSTIC FIBROSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 74. UNITED STATES CYSTIC FIBROSIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 75. UNITED STATES CYSTIC FIBROSIS MARKET SIZE, BY CFTR MODULATOR THERAPY, 2018-2024 (USD MILLION)
TABLE 76. UNITED STATES CYSTIC FIBROSIS MARKET SIZE, BY CFTR MODULATOR THERAPY, 2025-2030 (USD MILLION)
TABLE 77. UNITED STATES CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 78. UNITED STATES CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 79. UNITED STATES CYSTIC FIBROSIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 80. UNITED STATES CYSTIC FIBROSIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 81. UNITED STATES CYSTIC FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 82. UNITED STATES CYSTIC FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 83. UNITED STATES CYSTIC FIBROSIS MARKET SIZE, BY OFFLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 84. UNITED STATES CYSTIC FIBROSIS MARKET SIZE, BY OFFLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES CYSTIC FIBROSIS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES CYSTIC FIBROSIS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 87. CANADA CYSTIC FIBROSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 88. CANADA CYSTIC FIBROSIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 89. CANADA CYSTIC FIBROSIS MARKET SIZE, BY CFTR MODULATOR THERAPY, 2018-2024 (USD MILLION)
TABLE 90. CANADA CYSTIC FIBROSIS MARKET SIZE, BY CFTR MODULATOR THERAPY, 2025-2030 (USD MILLION)
TABLE 91. CANADA CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 92. CANADA CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 93. CANADA CYSTIC FIBROSIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 94. CANADA CYSTIC FIBROSIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 95. CANADA CYSTIC FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 96. CANADA CYSTIC FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 97. CANADA CYSTIC FIBROSIS MARKET SIZE, BY OFFLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 98. CANADA CYSTIC FIBROSIS MARKET SIZE, BY OFFLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 99. MEXICO CYSTIC FIBROSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 100. MEXICO CYSTIC FIBROSIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 101. MEXICO CYSTIC FIBROSIS MARKET SIZE, BY CFTR MODULATOR THERAPY, 2018-2024 (USD MILLION)
TABLE 102. MEXICO CYSTIC FIBROSIS MARKET SIZE, BY CFTR MODULATOR THERAPY, 2025-2030 (USD MILLION)
TABLE 103. MEXICO CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 104. MEXICO CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 105. MEXICO CYSTIC FIBROSIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 106. MEXICO CYSTIC FIBROSIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 107. MEXICO CYSTIC FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 108. MEXICO CYSTIC FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 109. MEXICO CYSTIC FIBROSIS MARKET SIZE, BY OFFLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 110. MEXICO CYSTIC FIBROSIS MARKET SIZE, BY OFFLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 111. BRAZIL CYSTIC FIBROSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 112. BRAZIL CYSTIC FIBROSIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 113. BRAZIL CYSTIC FIBROSIS MARKET SIZE, BY CFTR MODULATOR THERAPY, 2018-2024 (USD MILLION)
TABLE 114. BRAZIL CYSTIC FIBROSIS MARKET SIZE, BY CFTR MODULATOR THERAPY, 2025-2030 (USD MILLION)
TABLE 115. BRAZIL CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 116. BRAZIL CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 117. BRAZIL CYSTIC FIBROSIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 118. BRAZIL CYSTIC FIBROSIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 119. BRAZIL CYSTIC FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 120. BRAZIL CYSTIC FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 121. BRAZIL CYSTIC FIBROSIS MARKET SIZE, BY OFFLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 122. BRAZIL CYSTIC FIBROSIS MARKET SIZE, BY OFFLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 123. ARGENTINA CYSTIC FIBROSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 124. ARGENTINA CYSTIC FIBROSIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 125. ARGENTINA CYSTIC FIBROSIS MARKET SIZE, BY CFTR MODULATOR THERAPY, 2018-2024 (USD MILLION)
TABLE 126. ARGENTINA CYSTIC FIBROSIS MARKET SIZE, BY CFTR MODULATOR THERAPY, 2025-2030 (USD MILLION)
TABLE 127. ARGENTINA CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 128. ARGENTINA CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 129. ARGENTINA CYSTIC FIBROSIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 130. ARGENTINA CYSTIC FIBROSIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 131. ARGENTINA CYSTIC FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 132. ARGENTINA CYSTIC FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 133. ARGENTINA CYSTIC FIBROSIS MARKET SIZE, BY OFFLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 134. ARGENTINA CYSTIC FIBROSIS MARKET SIZE, BY OFFLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS MARKET SIZE, BY CFTR MODULATOR THERAPY, 2018-2024 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS MARKET SIZE, BY CFTR MODULATOR THERAPY, 2025-2030 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS MARKET SIZE, BY OFFLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS MARKET SIZE, BY OFFLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 149. UNITED KINGDOM CYSTIC FIBROSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 150. UNITED KINGDOM CYSTIC FIBROSIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 151. UNITED KINGDOM CYSTIC FIBROSIS MARKET SIZE, BY CFTR MODULATOR THERAPY, 2018-2024 (USD MILLION)
TABLE 152. UNITED KINGDOM CYSTIC FIBROSIS MARKET SIZE, BY CFTR MODULATOR THERAPY, 2025-2030 (USD MILLION)
TABLE 153. UNITED KINGDOM CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 154. UNITED KINGDOM CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 155. UNITED KINGDOM CYSTIC FIBROSIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 156. UNITED KINGDOM CYSTIC FIBROSIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 157. UNITED KINGDOM CYSTIC FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 158. UNITED KINGDOM CYSTIC FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 159. UNITED KINGDOM CYSTIC FIBROSIS MARKET SIZE, BY OFFLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 160. UNITED KINGDOM CYSTIC FIBROSIS MARKET SIZE, BY OFFLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 161. GERMANY CYSTIC FIBROSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 162. GERMANY CYSTIC FIBROSIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 163. GERMANY CYSTIC FIBROSIS MARKET SIZE, BY CFTR MODULATOR THERAPY, 2018-2024 (USD MILLION)
TABLE 164. GERMANY CYSTIC FIBROSIS MARKET SIZE, BY CFTR MODULATOR THERAPY, 2025-2030 (USD MILLION)
TABLE 165. GERMANY CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 166. GERMANY CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 167. GERMANY CYSTIC FIBROSIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 168. GERMANY CYSTIC FIBROSIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 169. GERMANY CYSTIC FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 170. GERMANY CYSTIC FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 171. GERMANY CYSTIC FIBROSIS MARKET SIZE, BY OFFLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 172. GERMANY CYSTIC FIBROSIS MARKET SIZE, BY OFFLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 173. FRANCE CYSTIC FIBROSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 174. FRANCE CYSTIC FIBROSIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 175. FRANCE CYSTIC FIBROSIS MARKET SIZE, BY CFTR MODULATOR THERAPY, 2018-2024 (USD MILLION)
TABLE 176. FRANCE CYSTIC FIBROSIS MARKET SIZE, BY CFTR MODULATOR THERAPY, 2025-2030 (USD MILLION)
TABLE 177. FRANCE CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 178. FRANCE CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 179. FRANCE CYSTIC FIBROSIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 180. FRANCE CYSTIC FIBROSIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 181. FRANCE CYSTIC FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 182. FRANCE CYSTIC FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 183. FRANCE CYSTIC FIBROSIS MARKET SIZE, BY OFFLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 184. FRANCE CYSTIC FIBROSIS MARKET SIZE, BY OFFLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 185. RUSSIA CYSTIC FIBROSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 186. RUSSIA CYSTIC FIBROSIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 187. RUSSIA CYSTIC FIBROSIS MARKET SIZE, BY CFTR MODULATOR THERAPY, 2018-2024 (USD MILLION)
TABLE 188. RUSSIA CYSTIC FIBROSIS MARKET SIZE, BY CFTR MODULATOR THERAPY, 2025-2030 (USD MILLION)
TABLE 189. RUSSIA CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 190. RUSSIA CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 191. RUSSIA CYSTIC FIBROSIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 192. RUSSIA CYSTIC FIBROSIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 193. RUSSIA CYSTIC FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 194. RUSSIA CYSTIC FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 195. RUSSIA CYSTIC FIBROSIS MARKET SIZE, BY OFFLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 196. RUSSIA CYSTIC FIBROSIS MARKET SIZE, BY OFFLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 197. ITALY CYSTIC FIBROSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 198. ITALY CYSTIC FIBROSIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 199. ITALY CYSTIC FIBROSIS MARKET SIZE, BY CFTR MODULATOR THERAPY, 2018-2024 (USD MILLION)
TABLE 200. ITALY CYSTIC FIBROSIS MARKET SIZE, BY CFTR MODULATOR THERAPY, 2025-2030 (USD MILLION)
TABLE 201. ITALY CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 202. ITALY CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 203. ITALY CYSTIC FIBROSIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 204. ITALY CYSTIC FIBROSIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 205. ITALY CYSTIC FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 206. ITALY CYSTIC FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 207. ITALY CYSTIC FIBROSIS MARKET SIZE, BY OFFLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 208. ITALY CYSTIC FIBROSIS MARKET SIZE, BY OFFLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 209. SPAIN CYSTIC FIBROSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 210. SPAIN CYSTIC FIBROSIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 211. SPAIN CYSTIC FIBROSIS MARKET SIZE, BY CFTR MODULATOR THERAPY, 2018-2024 (USD MILLION)
TABLE 212. SPAIN CYSTIC FIBROSIS MARKET SIZE, BY CFTR MODULATOR THERAPY, 2025-2030 (USD MILLION)
TABLE 213. SPAIN CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 214. SPAIN CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 215. SPAIN CYSTIC FIBROSIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 216. SPAIN CYSTIC FIBROSIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 217. SPAIN CYSTIC FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 218. SPAIN CYSTIC FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 219. SPAIN CYSTIC FIBROSIS MARKET SIZE, BY OFFLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 220. SPAIN CYSTIC FIBROSIS MARKET SIZE, BY OFFLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 221. UNITED ARAB EMIRATES CYSTIC FIBROSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 222. UNITED ARAB EMIRATES CYSTIC FIBROSIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 223. UNITED ARAB EMIRATES CYSTIC FIBROSIS MARKET SIZE, BY CFTR MODULATOR THERAPY, 2018-2024 (USD MILLION)
TABLE 224. UNITED ARAB EMIRATES CYSTIC FIBROSIS MARKET SIZE, BY CFTR MODULATOR THERAPY, 2025-2030 (USD MILLION)
TABLE 225. UNITED ARAB EMIRATES CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 226. UNITED ARAB EMIRATES CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 227. UNITED ARAB EMIRATES CYSTIC FIBROSIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 228. UNITED ARAB EMIRATES CYSTIC FIBROSIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 229. UNITED ARAB EMIRATES CYSTIC FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 230. UNITED ARAB EMIRATES CYSTIC FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 231. UNITED ARAB EMIRATES CYSTIC FIBROSIS MARKET SIZE, BY OFFLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 232. UNITED ARAB EMIRATES CYSTIC FIBROSIS MARKET SIZE, BY OFFLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 233. SAUDI ARABIA CYSTIC FIBROSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 234. SAUDI ARABIA CYSTIC FIBROSIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 235. SAUDI ARABIA CYSTIC FIBROSIS MARKET SIZE, BY CFTR MODULATOR THERAPY, 2018-2024 (USD MILLION)
TABLE 236. SAUDI ARABIA CYSTIC FIBROSIS MARKET SIZE, BY CFTR MODULATOR THERAPY, 2025-2030 (USD MILLION)
TABLE 237. SAUDI ARABIA CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 238. SAUDI ARABIA CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 239. SAUDI ARABIA CYSTIC FIBROSIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 240. SAUDI ARABIA CYSTIC FIBROSIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 241. SAUDI ARABIA CYSTIC FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 242. SAUDI ARABIA CYSTIC FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 243. SAUDI ARABIA CYSTIC FIBROSIS MARKET SIZE, BY OFFLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 244. SAUDI ARABIA CYSTIC FIBROSIS MARKET SIZE, BY OFFLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 245. SOUTH AFRICA CYSTIC FIBROSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 246. SOUTH AFRICA CYSTIC FIBROSIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 247. SOUTH AFRICA CYSTIC FIBROSIS MARKET SIZE, BY CFTR MODULATOR THERAPY, 2018-2024 (USD MILLION)
TABLE 248. SOUTH AFRICA CYSTIC FIBROSIS MARKET SIZE, BY CFTR MODULATOR THERAPY, 2025-2030 (USD MILLION)
TABLE 249. SOUTH AFRICA CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 250. SOUTH AFRICA CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 251. SOUTH AFRICA CYSTIC FIBROSIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 252. SOUTH AFRICA CYSTIC FIBROSIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 253. SOUTH AFRICA CYSTIC FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 254. SOUTH AFRICA CYSTIC FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 255. SOUTH AFRICA CYSTIC FIBROSIS MARKET SIZE, BY OFFLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 256. SOUTH AFRICA CYSTIC FIBROSIS MARKET SIZE, BY OFFLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 257. DENMARK CYSTIC FIBROSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 258. DENMARK CYSTIC FIBROSIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 259. DENMARK CYSTIC FIBROSIS MARKET SIZE, BY CFTR MODULATOR THERAPY, 2018-2024 (USD MILLION)
TABLE 260. DENMARK CYSTIC FIBROSIS MARKET SIZE, BY CFTR MODULATOR THERAPY, 2025-2030 (USD MILLION)
TABLE 261. DENMARK CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 262. DENMARK CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 263. DENMARK CYSTIC FIBROSIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 264. DENMARK CYSTIC FIBROSIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 265. DENMARK CYSTIC FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 266. DENMARK CYSTIC FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 267. DENMARK CYSTIC FIBROSIS MARKET SIZE, BY OFFLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 268. DENMARK CYSTIC FIBROSIS MARKET SIZE, BY OFFLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 269. NETHERLANDS CYSTIC FIBROSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 270. NETHERLANDS CYSTIC FIBROSIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 271. NETHERLANDS CYSTIC FIBROSIS MARKET SIZE, BY CFTR MODULATOR THERAPY, 2018-2024 (USD MILLION)
TABLE 272. NETHERLANDS CYSTIC FIBROSIS MARKET SIZE, BY CFTR MODULATOR THERAPY, 2025-2030 (USD MILLION)
TABLE 273. NETHERLANDS CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 274. NETHERLANDS CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 275. NETHERLANDS CYSTIC FIBROSIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 276. NETHERLANDS CYSTIC FIBROSIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 277. NETHERLANDS CYSTIC FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 278. NETHERLANDS CYSTIC FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 279. NETHERLANDS CYSTIC FIBROSIS MARKET SIZE, BY OFFLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 280. NETHERLANDS CYSTIC FIBROSIS MARKET SIZE, BY OFFLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 281. QATAR CYSTIC FIBROSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 282. QATAR CYSTIC FIBROSIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 283. QATAR CYSTIC FIBROSIS MARKET SIZE, BY CFTR MODULATOR THERAPY, 2018-2024 (USD MILLION)
TABLE 284. QATAR CYSTIC FIBROSIS MARKET SIZE, BY CFTR MODULATOR THERAPY, 2025-2030 (USD MILLION)
TABLE 285. QATAR CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 286. QATAR CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 287. QATAR CYSTIC FIBROSIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 288. QATAR CYSTIC FIBROSIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 289. QATAR CYSTIC FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 290. QATAR CYSTIC FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 291. QATAR CYSTIC FIBROSIS MARKET SIZE, BY OFFLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 292. QATAR CYSTIC FIBROSIS MARKET SIZE, BY OFFLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 293. FINLAND CYSTIC FIBROSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 294. FINLAND CYSTIC FIBROSIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 295. FINLAND CYSTIC FIBROSIS MARKET SIZE, BY CFTR MODULATOR THERAPY, 2018-2024 (USD MILLION)
TABLE 296. FINLAND CYSTIC FIBROSIS MARKET SIZE, BY CFTR MODULATOR THERAPY, 2025-2030 (USD MILLION)
TABLE 297. FINLAND CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 298. FINLAND CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 299. FINLAND CYSTIC FIBROSIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 300. FINLAND CYSTIC FIBROSIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 301. FINLAND CYSTIC FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 302. FINLAND CYSTIC FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 303. FINLAND CYSTIC FIBROSIS MARKET SIZE, BY OFFLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 304. FINLAND CYSTIC FIBROSIS MARKET SIZE, BY OFFLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 305. SWEDEN CYSTIC FIBROSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 306. SWEDEN CYSTIC FIBROSIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 307. SWEDEN CYSTIC FIBROSIS MARKET SIZE, BY CFTR MODULATOR THERAPY, 2018-2024 (USD MILLION)
TABLE 308. SWEDEN CYSTIC FIBROSIS MARKET SIZE, BY CFTR MODULATOR THERAPY, 2025-2030 (USD MILLION)
TABLE 309. SWEDEN CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 310. SWEDEN CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 311. SWEDEN CYSTIC FIBROSIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 312. SWEDEN CYSTIC FIBROSIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 313. SWEDEN CYSTIC FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 314. SWEDEN CYSTIC FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 315. SWEDEN CYSTIC FIBROSIS MARKET SIZE, BY OFFLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 316. SWEDEN CYSTIC FIBROSIS MARKET SIZE, BY OFFLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 317. NIGERIA CYSTIC FIBROSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 318. NIGERIA CYSTIC FIBROSIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 319. NIGERIA CYSTIC FIBROSIS MARKET SIZE, BY CFTR MODULATOR THERAPY, 2018-2024 (USD MILLION)
TABLE 320. NIGERIA CYSTIC FIBROSIS MARKET SIZE, BY CFTR MODULATOR THERAPY, 2025-2030 (USD MILLION)
TABLE 321. NIGERIA CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 322. NIGERIA CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 323. NIGERIA CYSTIC FIBROSIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 324. NIGERIA CYSTIC FIBROSIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 325. NIGERIA CYSTIC FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 326. NIGERIA CYSTIC FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 327. NIGERIA CYSTIC FIBROSIS MARKET SIZE, BY OFFLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 328. NIGERIA CYSTIC FIBROSIS MARKET SIZE, BY OFFLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 329. EGYPT CYSTIC FIBROSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 330. EGYPT CYSTIC FIBROSIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 331. EGYPT CYSTIC FIBROSIS MARKET SIZE, BY CFTR MODULATOR THERAPY, 2018-2024 (USD MILLION)
TABLE 332. EGYPT CYSTIC FIBROSIS MARKET SIZE, BY CFTR MODULATOR THERAPY, 2025-2030 (USD MILLION)
TABLE 333. EGYPT CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 334. EGYPT CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 335. EGYPT CYSTIC FIBROSIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 336. EGYPT CYSTIC FIBROSIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 337. EGYPT CYSTIC FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 338. EGYPT CYSTIC FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 339. EGYPT CYSTIC FIBROSIS MARKET SIZE, BY OFFLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 340. EGYPT CYSTIC FIBROSIS MARKET SIZE, BY OFFLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 341. TURKEY CYSTIC FIBROSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 342. TURKEY CYSTIC FIBROSIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 343. TURKEY CYSTIC FIBROSIS MARKET SIZE, BY CFTR M

Samples

Loading
LOADING...

Companies Mentioned

  • Vertex Pharmaceuticals Incorporated
  • F. Hoffmann-La Roche Ltd
  • Novartis AG
  • Gilead Sciences, Inc.
  • Teva Pharmaceutical Industries Ltd
  • Viatris Inc.
  • Sun Pharmaceutical Industries Ltd
  • Cipla Limited
  • Lupin Limited
  • AbbVie

Table Information

Report AttributeDetails
No. of Pages187
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 7.07 Billion
Forecasted Market Value ( USD ) by 2030 $ 11.14 Billion
Compound Annual Growth Rate9.5%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Cystic Fibrosis Therapeutics Market Size, Share & Trends Analysis Report by Drug Class (Pancreatic Enzyme Supplements), Route of Administration (Oral), Distribution Channel, Region, and Segment Forecasts, 2025-2030 - Product Image

Cystic Fibrosis Therapeutics Market Size, Share & Trends Analysis Report by Drug Class (Pancreatic Enzyme Supplements), Route of Administration (Oral), Distribution Channel, Region, and Segment Forecasts, 2025-2030

  • Report
  • 90 Pages
  • Global
From
Cystic Fibrosis (CF) Therapeutics Market Report 2025 - Product Image

Cystic Fibrosis (CF) Therapeutics Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Cystic Fibrosis Therapeutics Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type - Product Image

Cystic Fibrosis Therapeutics Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • 92 Pages
  • Global
From
Cystic Fibrosis Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Cystic Fibrosis Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Cystic Fibrosis Therapeutics - Global Strategic Business Report - Product Image

Cystic Fibrosis Therapeutics - Global Strategic Business Report

  • Report
  • 282 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.